Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Life Sciences Research, Inc. - LSR

NEW YORK, NY, Jul 10 (MARKET WIRE) --
Levi & Korsinsky announces that a class action lawsuit has been filed in
the Superior Court of the State of New Jersey challenging the proposed
acquisition of Life Sciences Research, Inc. ("Life Sciences" or the
"Company") (NYSE: LSR).

The Complaint arises out of the announcement by Life Sciences to sell the
Company to Lion Holdings, Inc., an entity that is controlled by Andrew
Baker, Chairman and CEO of Life Sciences. Under the terms of the
agreement, Life Sciences shareholders will receive $8.50 in cash for each
share of Life Sciences they own, or a total transaction value of
approximately $113 million. This raises questions as to whether the Life
Sciences Board of Directors breached their fiduciary duties to
shareholders given that: (i) the Company's shares traded at $9.83 as
recently as January 5, 2009 and over $32 per share in the fourth quarter
of 2008; (ii) at least one analyst set a price target for Life Sciences
stock at $20 per share; and (iii) the Company agreed to a
non-solicitation provision and a termination fee of up to $4,460,000 that
will all but ensure that no superior offer will ever be forthcoming.

The Company expects to consummate the transaction in the fourth quarter,
subject to customary closing conditions, including all necessary
regulatory and stockholder approvals.

If you own common stock in Life Sciences and wish to obtain additional
information, please contact us at the number listed below or visit
www.zlk.com/lsr1.html

Levi & Korsinsky has expertise in prosecuting investor securities
litigation and extensive experience in actions involving financial fraud
and represents investors throughout the nation, concentrating its practice
in securities and shareholder litigation.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Juan E. Monteverde, Esq.
30 Broad Street -15th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

Copyright 2009, Market Wire, All rights reserved.

-0-